Cidine 1mg Tablets (14s)

Cidine contains cinitapride 1 mg, a gastrointestinal prokinetic medicine used to improve upper gastrointestinal motility. It is supplied as oral tablets in a pack of 14 and is manufactured by Highnoon.

• Manufacturer Name: Highnoon
• Drug Class: Gastrointestinal prokinetic; 5-HT4 receptor agonist and dopamine D2 receptor antagonist
• Dosage Form: Tablet
• Storage: Store at room temperature in a dry place, protected from heat, moisture, and direct light. Keep out of reach of children.
• Pack Size: Pack of 14 Tablets

Cidine 1mg Tablets (14s) Available Online in Pakistan

Dwatson offers Cidine 1mg Tablets (14s) at Rs.521, with fast, discreet delivery across Pakistan.

• Cinitapride 1 mg

• Functional dyspepsia
• Post-meal fullness, early satiety, bloating, and related indigestion symptoms
• Delayed gastric emptying and upper gastrointestinal motility symptoms when prescribed by a clinician

For Adult

• The usual adult dose is 1 mg orally three times daily.
• Take approximately 15 minutes before meals.
• Use only as directed by a healthcare professional; dose adjustment may be needed in older adults or patients with significant medical conditions.

For Children

• Safety and effectiveness in children have not been adequately established.
• Do not use in children, including those weighing less than 20 kg, unless specifically prescribed and supervised by a pediatric healthcare professional.

Side Effects

• Possible effects include abdominal discomfort, diarrhea, constipation, nausea, headache, dizziness, or drowsiness.
• Rarely, abnormal involuntary movements, muscle stiffness, tremor, restlessness, or other extrapyramidal symptoms may occur.
• Stop use and seek urgent medical attention for severe allergic reactions, fainting, palpitations, severe muscle spasms, or unusual changes in consciousness.

Contraindications

• Do not use in patients with known allergy to cinitapride or any tablet ingredient.
• Avoid use in gastrointestinal bleeding, obstruction, perforation, or conditions where increased gastrointestinal motility could be harmful.
• Use cautiously in patients with a history of movement disorders, seizures, significant cardiac disease, or clinically important electrolyte abnormalities.
• Seek medical advice before use if persistent vomiting, severe abdominal pain, abdominal swelling, or blood in the stool is present.

Precautions & Warnings

• Anticholinergic medicines may reduce the gastrointestinal effects of cinitapride.
• Other medicines that increase gastrointestinal motility may enhance its effects.
• Caution is advised with medicines that can cause drowsiness or affect movement, including sedatives and some medicines acting on the central nervous system.
• Medicines that inhibit CYP3A4 or CYP2C8, such as ketoconazole, may increase cinitapride exposure; consult a healthcare professional before combining them.
• Avoid or limit alcohol because it may increase dizziness or drowsiness.

• Use during pregnancy only if clearly prescribed after medical assessment, because adequate human safety data are limited.
• Inform the healthcare professional if pregnant or planning pregnancy.
• It is not established whether cinitapride passes into breast milk; breastfeeding use should be discussed with a healthcare professional.